Policy and Legislation
The U.S. Department of Health and Human Services' Office of Civil Rights outlined several circumstances in which the disclosures of protected health information with public health authorities are permitted under HIPAA.
Today, pharmacies began administering Pfizer vaccine to residents and staff of long-term care facilities.
Congress continues to debate a $900 billion relief bill that would include funds for vaccine distribution and testing and relief for hospitals.
The FDA is recommending surveillance of Bell’s palsy after four Moderna trial participants developed the temporary facial paralysis.
The letter’s recommendations surround relief, recovery, rebuilding and addressing ongoing challenges in equity, workforce and behavioral health.
A growing number of drug companies have refused to provide discounts after an HHS decision to cut payments by 30% was upheld on appeal.
In lieu of permanent policy change, industry groups urged legislators to extend temporary telehealth flexibilities through the end of 2021.
The additional doses ordered are projected to provide for continuous delivery through the end of June 2021.
The rule would reduce the time providers wait to receive prior authorization from payers to a maximum of 72 hours.
Terry Boch, Diameter Health's chief commercial officer, talks about the regulatory and data landscape in health tech, including data quality issues.